CompaniesByCap
MTNB
Matinas Biopharma Holdings Inc. (MTNB)
NYSE · Healthcare

Matinas Biopharma Holdings Inc. Income Statement 2014–2023

Income StatementBalance SheetCash Flow
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014
Revenues
Revenue1.1M3.2M33,000158,33389,812119,750149,6870194,4940
Gross Profit
Profitability
Operating Income-23.8M-24.6M-24.7M-24.2M-18.9M-14.6M-16.5M-8.3M-9.9M-10.5M
EBITDA-23.4M-24.3M-24.5M-24.0M-18.7M-14.4M-16.4M-8.2M-9.9M-10.4M
Net Income-22.9M-21.0M-23.3M-22.4M-17.4M-14.1M-15.5M-7.6M-9.1M-10.2M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)4M217M216M200M163M113M93M58M57M32M

Matinas Biopharma Holdings Inc. Income Statement — FAQ

Matinas Biopharma Holdings Inc. (MTNB) income statement over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see MTNB's income statement history?

The chart and table above show Matinas Biopharma Holdings Inc.'s income statement by year and by quarter, including the growth rate.